Hints and tips:
Related Special Reports
...Last year, it also studied a bid for US investment giant Carlyle Group, the FT previously reported.Kreos has targeted a net internal rate of return in the low teens....
...Veritas Capital is in talks to sell a 50 per cent stake in healthcare technology company Cotiviti to private equity giant KKR, in a deal that would value the business at up to $11bn, according to three people...
...The president of New York’s Lincoln Center for the Performing Arts has been named as CEO-designate of public relations firm Brunswick....
...She joins from private equity group Carlyle....
...Carlyle Group has abandoned its long-planned investment in healthcare analytics company Cotiviti, according to people briefed on the matter, dealing a blow to the private equity firm as it struggles to raise...
...When Fink and GIP founder Adebayo Ogunlesi met for an October dinner at Fasano, an Italian restaurant steps away from Rockefeller Center in New York, the menu included plans for a combination that could...
...Google said the $105mn it is spending for the Thompson Center will help serve a hybrid labour force that works in and out of the office....
...It was mostly sealed over an October dinner between Fink and GIP chair and co-founder Adebayo Ogunlesi at Fasano, an Italian restaurant near Rockefeller Center....
...“Banks are nervous to underwrite single-B credit with M&A timelines which could be six months of holding the risk,” said Lauren Basmadjian, co-head of liquid credit at Carlyle....
...Earlier this year, several private equity firms including Blackstone, Carlyle, and EQT were considering a bid for Sandoz, according to people familiar with the situation....
...The group focuses on making minority and control investments in technology, consumer, healthcare and business services companies....
...Russian officials are yet to outline “a clear strategy for dealing with frozen assets”, said Aleksandra Prokopenko, a non-resident scholar at the Carnegie Russia Eurasia Center, adding that they were “likely...
...the cost and availability of healthcare....
...The process is due to begin in earnest in September when the Centers for Medicare & Medicaid Services (CMS) is due to identify 10 expensive drugs that will be the focus of the negotiation....
...Its key target in moving “beyond nicotine”, to generate $1bn in revenues from its wellness and healthcare division by 2025, is “questionable”, he admitted. Vectura’s figures aren’t disclosed....
...If you wanted to know what stage of the cycle private equity is in, Kim Kardashian last year launching a PE firm with a former Carlyle executive is pretty hard to beat....
...“It’s essentially a black box, in terms of the origins of the money,” says Lily McElwee, a China expert at the Center for Strategic and International Studies in Washington....
...A recent study co-funded by the Chinese Center for Disease Control and Prevention found that the country needed to make antivirals such as Paxlovid available to 160mn elderly people with underlying health...
...Eli Lilly, Amgen, Pfizer and Regeneron are among the companies aiming to compete with market leader Novo Nordisk in a category which analysts say is rapidly becoming a healthcare priority and could produce...
...Additional reporting by Kim Dung Tong in Ho Chi Minh City and Yuji Kuronuma in Tokyo A version of this article was first published by Nikkei Asia on January 6 2023. ©2023 Nikkei Inc....
...One of its biggest setbacks was the disastrous launch of aducanumab, which prompted the US Centers for Medicare & Medicaid Services to severely restrict reimbursement for all amyloid-reducing monoclonal...
...The Biden administration is gearing up to begin vaccinations for young children next week and is making 10mn doses available for distribution, pending a final recommendation in favour by the Centers for...
...Some healthcare experts believe the vaccine could win over vaccine sceptics who have so far resisted getting jabs....
...Walid Gellad, director of the Center for Pharmaceutical Policy and Prescribing at the University of Pittsburgh, said the drug works well for higher-risk patients, but there is still a lot of uncertainty...
...Carlyle’s global head of investor relations Nathan Urquhart is leaving the private equity group to become president of hedge fund Coatue Management, according to sources....
International Edition